Post TAVR Cognitive Function at Short Term: Better or Worse?

Post TAVR Cognitive Function at Short TermThere is little information on the short and mid-term evolution of cognitive function after transcatheter aortic valve replacement (TAVR).

 

The aim of this study was to describe global changes in cognitive function and changes in specific cognitive domains one year after TAVR.

 

Fifty one patients undergoing TAVR, median age 80, were prospectively followed to assess cognitive function using the Montreal Cognitive Assessment Test (MoCA) at baseline, 30 days and one year. Specific cognitive functions (e.g. verbal fluency) were assessed with pertinent tests.

 

Baseline MoCA outcomes, which assesses cognition globally, was 22.71 ± 3.84. Twenty patients (39.2%) showed cognitive decline at baseline, according to test results (<23 of 30 points).

 

MoCA scores improved at short term after TAVR and remained stable at one year (p = 0.022). There were no significant changes over time in specific cognitive domain test outcomes.

 

Conclusion

TAVR improves cognitive function, which is more obvious in patients presenting cognitive decline at baseline. There was also early decline of some specific functions in one quarter of patients that persisted at one year in 10% of these patients.

 

Original Title: Serial Changes in Cognitive Function Following Transcatheter Aortic Valve Replacement.

Reference: Vincent Auffret et al. J Am Coll Cardiol. 2016;68(20):2129-2141.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

TAVR in Pure Native Aortic Regurgitation: Are Dedicated Devices Truly Superior?

This systematic meta-analysis assessed the efficacy and safety of transcatheter aortic valve replacement (TAVR) in patients with pure native aortic regurgitation. The emergence of...

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....